Clinical Trial Results: Nirogacestat in Ovarian Granulosa Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for nirogacestat in ovarian granulosa cell tumors have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Granulosa Cell Tumor
• Ovarian Granulosa-stromal Tumor

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | Conditions: Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor | Phase 2 | Status: COMPLETED | Results posted: 2026-08-25